ProBiotix Health Reports 45% Sales Increase; Pulsar Helium Acquires 80% Stake in Quantum Hydrogen
ProBiotix Health reported a 45% increase in sales to £2.72 million for 2025 while reducing losses, and is focusing on growth in the Asia Pacific region after entering the Korean market. Meanwhile, Pulsar Helium acquired an 80% stake in Quantum Hydrogen and has the option to buy the remaining shares for $400,000. Other notable developments include Astrid Intelligence's acquisition of TaoFi and Kitwave Group's support for a cash bid from OEP Partners.
Theia Market Signal Identification - AI Assisted
ProBiotix Health (PBX) reported a 45% increase in sales to £2.72 million in 2025, while reducing losses. The company entered the Korean market and submitted applications for two new clinical trials. It ended the year with £1.27 million in the bank and an order book valued at £1.3 million, focusing on growth in the Asia Pacific region.
Pulsar Helium (PLSR) issued 145,434 shares to Oscillate (SRVL), increasing its stake in Quantum Hydrogen to 80%, with an option to acquire the remaining shares for $400,000. Astrid Intelligence (ASTR) acquired TaoFi, enhancing its service offerings.
Other highlights include Kitwave Group (KITW) supporting a cash bid of 295p/share from OEP Partners, and Shield Therapeutics (STX) aiming for operating profit in 2026 after revenue growth in 2025. Block Energy (BLOE) completed a farm-out of licence XIQ in Georgia, and Goldstone Resources (GRL) seeks to raise £2 million for exploration in Ghana.
Comments